Across TCGA pan-cancer cohorts, MMACHC RNA is linked to patient survival in 27 of 34 cancer types, making it the most broadly survival-associated MMACHC data layer compared with 3 for mutation status and 3 for mass-spec protein.
The strongest signal is observed in kidney chromophobe (KICH), where higher MMACHC RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MMACHC expression acts as an unfavorable survival marker, although some lineages such as READ and KIRC show a favorable association.
KICH, LGG, and READ are the cancer types where MMACHC RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.